Search filters

List of works by Régent Laporte

A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock

scientific article

Effects of exercise on skeletal muscle and serum enzyme activities in pigs

scientific article published on 01 January 1989

Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C

scientific article published on 01 November 1992

New, potent, selective, and short-acting peptidic V1a receptor agonists.

scientific article published on 20 June 2011

Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1aReceptor Full Agonist for the Treatment of Vasodilatory Hypotension

scientific article published on March 16, 2011

Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylation

scientific article published on 01 March 1994

Sarcoplasmic Reticulum-Sarcolemma Interactions and Vascular Smooth Muscle Tone

scientific article published on September 1, 1997

Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit.

scientific article

Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance.

scientific article

The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*

scientific article

Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor.

scientific article published on June 2012

Vasopressin in vasodilatory shock: is the heart in danger?

scientific article published on 10 April 2008